Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer

Jolien Heukelom, Olga Hamming, Harry Bartelink*, Frank Hoebers, Jordi Giralt, Teresa Herlestam, Marcel Verheij, Michiel van den Brekel, Wouter Vogel, Nick Slevin, Eric Deutsch, Jan-Jakob Sonke, Philippe Lambin, Coen Rasch

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

64 Citations (Web of Science)
Original languageEnglish
Article number84
JournalBMC Cancer
Volume13
DOIs
Publication statusPublished - 22 Feb 2013

Keywords

  • Head and neck
  • Squamous cell carcinoma
  • Adaptive radiotherapy
  • Dose painting
  • Zirconium
  • Cetuximab
  • Cisplatin

Cite this